News

Outstanding First Quarter Results for Moatable, Inc. Revealed

Outstanding First Quarter Results for Moatable, Inc. Revealed

Moatable, Inc. Announces Strong Growth in First Quarter Financial Results

Moatable, Inc. (OTC Pink: MTBLY) is excited to share its financial results for the first quarter of 2025, demonstrating continuous strides in revenue growth and profitability. The Company, a notable player in the SaaS sector, has made remarkable progress as of March 31, 2025.

Financial Highlights of the First Quarter

This quarter showcased an impressive 29% revenue increase, growing from $14.0 million in the prior year to $18.0 million in Q1 2025. This marks another quarter of solid financial performance for Moatable, showcasing its resilience in a competitive market.

Robust Revenue and Profit Growth

The significant revenue growth was accompanied by a gross profit increase of 25%. This ascended from $10.7 million in Q1 2024 to $13.4 million in the current quarter, reflecting an effective cost management strategy and a robust demand for Moatable's software solutions.

Improvement in Operational Losses

Further illustrating the Company's progress, the loss from operations has also improved significantly, decreasing from $1.4 million in 2024 to $1.0 million in Q1 2025, a 29% improvement. This forward momentum indicates Moatable's strategic focus on reducing operational costs while maintaining high service levels.

Cash Position and Future Outlook

At the end of the quarter, Moatable reported total cash and cash equivalents, along with restricted cash, amounting to $24.1 million. This strong cash position provides the Company with adequate resources to continue its growth trajectory and invest in new opportunities.

Management Commentary

Scott Stone, Chief Financial Officer at Moatable, expressed his satisfaction with the results: “Our consistent revenue growth over the past thirteen quarters is a testament to our team's hard work and dedication. We have seen our revenue increase by 75% from $10.3 million in Q1 2022 to $18.0 million this quarter.” This consistent performance underlines the Company's focus on maintaining a path towards profitability while enhancing efficiency.

About Moatable, Inc.

Moatable, Inc. operates two successful SaaS businesses: Lofty and Trucker Path. The firm is dedicated to enabling seamless tech solutions within the transportation and logistics sectors, enhancing user experience and operational efficiency. Moatable’s American depositary shares trade on OTC Pink under the symbol "MTBLY".

Frequently Asked Questions

What are the key financial highlights for Moatable in Q1 2025?

Moatable reported a 29% revenue increase, gross profit growth of 25%, and a reduced loss from operations of $1.0 million.

How has Moatable's revenue changed over the past years?

The Company has demonstrated a 75% increase in revenue from $10.3 million in Q1 2022 to $18.0 million in Q1 2025.

What is Moatable, Inc.'s current cash position?

As of the end of Q1 2025, Moatable holds $24.1 million in total cash and cash equivalents, indicating a strong financial position.

Who is the CFO of Moatable?

Scott Stone serves as the Chief Financial Officer of Moatable, overseeing the Company's financial performance and strategies.

What sectors does Moatable operate in?

Moatable operates in the SaaS sector with two businesses focused on enhancing operational efficiency in transportation and logistics.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting New Stamp Releases: 'Goodnight Moon' and 'SpongeBob'

Updated Category News Views 299

New Stamp Releases from the U.S. Postal Service The U.S. Postal Service has exciting news for fans of classic children's literature and beloved animated series. This year, they will introduce two charming stamps featuring the beloved stories 'Goodnight Moon' and 'SpongeBob SquarePants'. These stamps are set to delight both collectors and fans of these iconic characters....

Continue Reading
Silvercrest Asset Management's Q3 Results Preview and Call

Updated Category News Views 164

Silvercrest Asset Management's Upcoming Announcement New York, October 28, 2025 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) is gearing up for its third quarter financial announcement. Scheduled for October 31, 2025, at 8:30 am Eastern Time, this call will provide insights into the company’s financial performance for the period ending...

Continue Reading
Understanding China's Economic Challenges and Future Strategies

Updated Category News Views 336

China's Economic Landscape and Recent Stimulus Measures China's recent economic stimulus efforts have drawn mixed reactions from investors and analysts alike. Many were anticipating a robust and comprehensive fiscal response, often referred to as a stimulus "bazooka," but the measures announced fell short of expectations. Morgan Stanley has provided insights into why the...

Continue Reading
KPMG Australia Sets a Benchmark in AI Management Certification

Updated Category News Views 97

KPMG Australia Achieves Landmark AI Management Certification KPMG Australia has made headlines as the first organization globally to earn certification from BSI for a management system that emphasizes safe artificial intelligence (AI) practices. This milestone marks a significant achievement in promoting the responsible usage of AI technologies. Understanding the BSI...

Continue Reading
Consello Welcomes Nick Mullen as Leader of Sports Advisory

Updated Category News Views 508

Consello's Appointment of Nick Mullen Consello, the leading global advisory and investing platform, has made a significant addition to its team by appointing Nick Mullen as the Head of its Sports Advisory Business. With a robust background spanning over a decade in sports marketing and private equity, Nick is poised to lead the evolution of Consello's sports business...

Continue Reading